MedPath

Evaluation of efficacy due to response by FDG-PET in breast cancers treated with neoadjuvant chemotherapy

Not Applicable
Conditions
Breast cancer
Registration Number
JPRN-UMIN000030408
Lead Sponsor
Hyogo College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
199
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with Li-Fraumeni syndrome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath